Advances in Ocular Surface Infections
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: closed (15 December 2023) | Viewed by 28943
Special Issue Editors
Interests: optometry; vision; ophthalmology; biological markers
Interests: contact lenses; ocular surface; dry eye; ocular microbiology; corneal infection
Special Issues, Collections and Topics in MDPI journals
Interests: innate immunity; bacterial infections; fungal infections; neutrophils; keratitis
Special Issue Information
Dear Colleagues,
Advances in ocular surface infections are needed across three domains: 1. epidemiology/prevention/prophylaxis; 2. diagnosis; 3. management.
The risk factors for ocular surface infections in developed countries are led by contact lenses and trauma in working-aged adults, and by surgical or other trauma and ocular-surface quality in older ages. In developing countries, trauma is the key risk factor. Novel ways to impart knowledge of risk factors and change behaviour are urgently needed, as contact lenses are marketed to more of our population, including young children (as myopia control), and environmental organisms are being altered with the effects of climate change and pollution on the microcosm. Several studies have shown complex genomic associations with susceptibility to ocular surface infection, which is an emerging field.
Infections of the ocular surface are in most cases difficult to diagnose clinically, relying on laboratory culture as a gold standard diagnosis, which returns a positive result in only around 50% of presumed cases. PCR is unable to determine active compared to quiescent infection. In practice, the use of ocular imaging for the posterior eye has grown exponentially over the past 10 years, but in the ocular surface, imaging advances are mainly confined to the research domain.
Most ocular surface infections are due to bacteria, and are treated successfully with antibiotics. However, the increase in global antibiotic resistance is challenging this paradigm, and alternative agents for treatment are urgently required. Fungal pathogens are more common causes of corneal infection in rural or tropical areas, and while rare, disease caused by other environmental pathogens such as Acanthamoeba results in a more severe outcome. The treatment options for these infections are more limited, and require attention. Herpesvirus ocular surface infections are also fraught with resistance to treatment. SARS-CoV-2 has been found in the tears of patients, and the cornea and conjunctiva both harbour the ACE2 receptors for the spike protein of the virus. Ophthalmic practice is familiar with epidemic adenovirus keratoconjunctivitis, which can cause the shutdown of services, so the cognizance of emerging viruses is crucial.
For the cornea, limiting damage due to scarring and uncontrolled inflammation is crucial, due to the requirement of highly organised transparent tissue and the barrier to internal eye infection, which can rapidly lead to loss of the eye. Currently, glucocorticosteroids and matrix metalloproteinases are administered as blunt tools with significant side effects. There is a window of opportunity to develop more specific agents, and to better understand ocular surface homeostasis to develop better-targeted biologics with fewer side effects.
Dr. Nicole Carnt
Prof. Dr. Fiona Stapleton
Prof. Dr. Eric Pearlman
Dr. Connie Tam
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- risk factors
- epidemiology
- keratitis
- conjunctivitis
- keratoconjunctivitis
- diagnosis
- treatment
- ocular surface
- infection
- inflammation
- prevention
- prophylaxis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.